https://www.thebodypro.com/category/adverse-events-comorbidities-hiv

Adverse Events, Comorbidities, and HIV

The Latest

Ivana Beesham
Conference Coverage

Experts Flummoxed By Conflicting New Data on STIs, HIV, and Long-Term Contraception in Sub-Saharan Africa

ECHO trial results and follow-up studies find unexpectedly low rates of some STIs among users of certain long-term hormonal contraceptives. They also find high HIV rates (unrelated to the contraceptives) that suggest considerable value for PrEP integration.

Syringe.
News

New Drug Approved for Complicated Urinary Tract and Intra-Abdominal Infections

The U.S. Food and Drug Administration has approved a three-drug regimen to treat complicated urinary tract infections and complicated intra-abdominal infections, both of which can be especially problematic for people living with HIV.

couple on the boardwalk surrounded by seagulls
News

This Week in HIV Research: When STIs Flock Together

July 18, 2019: Anal neoplasia risk amidst comorbid HPV and chlamydia; predictive modeling for PrEP outreach; long-term benefits of hepatitis C cure in coinfection; first-line therapy with dolutegravir/lamivudine.

Mexico City's Downtown At Twilight
Conference Coverage

IAS 2019: What to Expect in HIV Science

Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.

Contraception pills on blue background
News

This Week in HIV Research: Cracking the Contraception Conundrum

July 11, 2019: Seroconversion while on long-acting contraceptives; cardiovascular risk in people with HIV; suboptimal testing in high-prevalence U.S. areas; E/C/F/TAF may be suitable for PEP.

Anchor on edge of boat
News

This Week in HIV Research: Weighing Anchor on NRTI-Free Treatment

June 27, 2019: Long-term viability of NRTI-free salvage therapy; factors associated with HIV treatment interruption; evolution of frailty risk among older people; skin and soft tissue infections among people with HIV.

Hepatitis C virion
Press Releases

Underwhelming Results From Hepatitis C Vaccine Trial

The 548-person U.S. study found that chronic hepatitis C infection occurred among an identical number of people who received the experimental vaccine compared to people who received a placebo.

Close up of sneakers walking up stairs
News

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

Collection of throat swab samples
News

CDC Study Reinforces the Importance of Annual STI Testing Among MSM

Rectal and throat tests matter too, and providers should be recommending them.

Magnifying glass on antique anatomy book: Heart image
News

This Week in HIV Research: Matters of the Heart

May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.